This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Univerzita Palackeho V Olomouci, Ustav Organicke Chemie a Biochemie Av Cr, V.v.i.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 36 
1 out of 38 
Years Active: 2022
Title: The Innovations of Lucia Veselovska: A Pioneer in Therapeutic Compounds
Introduction
Lucia Veselovska, an accomplished inventor from Liptovska Luzna, Slovakia, has made significant strides in the field of medicinal chemistry. Her innovative work has led to the development of compounds with promising therapeutic applications. With a focus on creating substituted pyridopyrrolopyrimidine ribonucleosides, she has contributed to the advancement of cancer therapeutics.
Latest Patents
Veselovska holds a patent for "Substituted pyridopyrrolopyrimidine ribonucleosides for therapeutic uses." The patent details compounds characterized by general formula I, wherein various groups such as thiophen-3-yl, furan-2-yl, furan-3-yl, benzofuran-2-yl, and several others are identified. This invention is notable for its cytostatic and cytotoxic effects on cancerous cell lines across diverse tumor types, highlighting its potential in treating a range of diseases.
Career Highlights
Throughout her career, Lucia has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and Palacký University in Olomouc. Her experiences in these reputable organizations have sharpened her expertise and fueled her passion for innovation in therapeutic development.
Collaborations
Lucia has collaborated with prominent colleagues, including Michal Hocek and Marian Hajduch. These partnerships have facilitated the exchange of ideas and expertise, reinforcing her contributions to the field of medicinal chemistry and enhancing the impact of her research on cancer treatment.
Conclusion
Lucia Veselovska's innovative work exemplifies the critical role of inventors in advancing therapeutic approaches in medicine. Her patent for substituted pyridopyrrolopyrimidine ribonucleosides showcases not only her inventiveness but also her commitment to addressing significant health challenges. As the landscape of cancer treatment continues to evolve, her contributions will undoubtedly play a vital role in shaping future therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile